Mesa Net Receivables from 2010 to 2026
| MLAB Stock | USD 91.95 1.14 1.26% |
Net Receivables | First Reported 1988-03-31 | Previous Quarter 40.1 M | Current Value 40.2 M | Quarterly Volatility 12.1 M |
Check Mesa Laboratories financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Mesa Laboratories' main balance sheet or income statement drivers, such as Interest Expense of 14.3 M, Total Revenue of 291 M or Gross Profit of 182.2 M, as well as many indicators such as Price To Sales Ratio of 2.92, Dividend Yield of 0.0059 or PTB Ratio of 2.38. Mesa financial statements analysis is a perfect complement when working with Mesa Laboratories Valuation or Volatility modules.
Mesa | Net Receivables | Build AI portfolio with Mesa Stock |
Analyzing Mesa Laboratories's Net Receivables over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Net Receivables has evolved provides context for assessing Mesa Laboratories's current valuation and future prospects.
Latest Mesa Laboratories' Net Receivables Growth Pattern
Below is the plot of the Net Receivables of Mesa Laboratories over the last few years. It is Mesa Laboratories' Net Receivables historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Mesa Laboratories' overall financial position and show how it may be relating to other accounts over time.
| Net Receivables | 10 Years Trend |
|
Net Receivables |
| Timeline |
Mesa Net Receivables Regression Statistics
| Arithmetic Mean | 23,629,193 | |
| Geometric Mean | 15,499,081 | |
| Coefficient Of Variation | 69.89 | |
| Mean Deviation | 14,367,874 | |
| Median | 15,313,000 | |
| Standard Deviation | 16,514,234 | |
| Sample Variance | 272.7T | |
| Range | 50.5M | |
| R-Value | 0.95 | |
| Mean Square Error | 26.8T | |
| R-Squared | 0.91 | |
| Slope | 3,115,860 | |
| Total Sum of Squares | 4363.5T |
Mesa Net Receivables History
About Mesa Laboratories Financial Statements
Mesa Laboratories stakeholders use historical fundamental indicators, such as Mesa Laboratories' Net Receivables, to determine how well the company is positioned to perform in the future. Although Mesa Laboratories investors may analyze each financial statement separately, they are all interrelated. For example, changes in Mesa Laboratories' assets and liabilities are reflected in the revenues and expenses on Mesa Laboratories' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Mesa Laboratories. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Net Receivables | 48.3 M | 50.7 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Mesa Laboratories offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Mesa Laboratories' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Mesa Laboratories Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Mesa Laboratories Stock:Check out the analysis of Mesa Laboratories Correlation against competitors. For information on how to trade Mesa Stock refer to our How to Trade Mesa Stock guide.You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mesa Laboratories. Expected growth trajectory for Mesa significantly influences the price investors are willing to assign. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Mesa Laboratories assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Quarterly Earnings Growth (0.29) | Dividend Share 0.64 | Earnings Share 0.65 | Revenue Per Share | Quarterly Revenue Growth 0.036 |
The market value of Mesa Laboratories is measured differently than its book value, which is the value of Mesa that is recorded on the company's balance sheet. Investors also form their own opinion of Mesa Laboratories' value that differs from its market value or its book value, called intrinsic value, which is Mesa Laboratories' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mesa Laboratories' market value can be influenced by many factors that don't directly affect Mesa Laboratories' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Understanding that Mesa Laboratories' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Mesa Laboratories represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Meanwhile, Mesa Laboratories' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.